MAPT and neurodegenerative disease: In this study we used two complementary animal models of protein misfolding neurodegenerative disease, with a prominent contribution of microglia, to validate the new selective CSF1R inhibitor JNJ-527 for the blockade of microglial proliferation and assess its efficacy in tau-induced neurodegeneration.